RESEARCH PEPTIDE
Ipamorelin 10 mg
Ipamorelin 10 mg
Ipamorelin is a selective GHRP-receptor agonist studied for pituitary growth-hormone release and secretagogue pharmacology.
Quality documentation
Certificate of Analysis Available
View the available testing documentation for Ipamorelin 10 mg.
IDR 1.999.000
- Product
- Ipamorelin
- Strength
- 10 mg
- Category
- Research Peptides
- Purity
- ≥99.6% PURITY
- Use
- Laboratory and scientific research only
- Price
- IDR 1.999.000
The power of selective secretagogue signalling.
Ipamorelin is a selective GHRP-receptor agonist studied for pituitary growth-hormone release and secretagogue pharmacology.
Research context
In cellular and animal models, ipamorelin stimulated growth-hormone release through a GHRP-like receptor while showing selectivity for growth hormone over several other pituitary outputs. These findings support receptor-pharmacology and endocrine-response research, not body-composition or recovery claims.
Research interests
- Growth hormone secretagogue signalling
- Pituitary response models
- Receptor-selectivity research
Explore further
Related research products
Research Peptides≥99.6% PURITY10 mg
AOD-9604 is a modified C-terminal growth-hormone fragment studied in preclinical lipid-metabolism, fat-oxidation, and adipose-signalling models.
≥99.6% PURITY
IDR 3.499.000
Research Peptides≥99.6% PURITY10 mg
BPC-157 is studied in preclinical models of tendon-fibroblast migration, FAK–paxillin activation, and tissue-repair signalling.
≥99.6% PURITY
IDR 1.199.000
Research Peptides≥99.6% PURITY5 mg
CJC-1295 is studied within growth hormone-releasing hormone research for its influence on GH and IGF-1 signalling.
≥99.6% PURITY
IDR 1.399.000
Research Peptides≥99.6% PURITY10 mg
DSIP is an exploratory neuropeptide studied at the intersection of slow-wave EEG activity, sleep signalling, and neuroendocrine regulation.
≥99.6% PURITY
IDR 2.199.000